logo
Select company
Select metric
$ -8.49MEarning Before Interest & Taxes (EBIT)
VS
Market
32
Sector
66
Industry
81
History
60
$ 8.24Close
$ 3.99 - $ 9.88 52-Week Range
Ticker Information

Ticker

FENC

Company Name

FENNEC PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

FENNEC PHARMACEUTICALS INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

FENC - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -8.49M
3/31/2025$ -10.45M
12/31/2024$ 4M
9/30/2024$ 3.79M
6/30/2024$ 7.49M
3/31/2024$ 7.38M
12/31/2023$ -12.65M
9/30/2023$ -17M
6/30/2023$ -23.96M
3/31/2023$ -24.35M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • FENNEC PHARMACEUTICALS INC's latest trailing twelve months (TTM) EBIT stands at $ -18.48M.
  • Over the past 5 years, FENNEC PHARMACEUTICALS INC's average EBIT has been $ -12.92M.
  • The median EBIT for FENNEC PHARMACEUTICALS INC during this period was $ -17.07M
  • FENNEC PHARMACEUTICALS INC reached its highest EBIT over the past 5 years at $ 7.49M.
  • The lowest EBIT recorded by FENNEC PHARMACEUTICALS INC in the same timeframe $ -24.35M

FENNEC PHARMACEUTICALS INC's EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT Benchmarks
CompanyEBIT
CCCC : C4 THERAPEUTICS INC $ -111.45MVYGR : VOYAGER THERAPEUTICS INC $ -107.25MEDIT : EDITAS MEDICINE INC $ -242.16MOABI : OMNIAB INC $ -68.37MFHTX : FOGHORN THERAPEUTICS INC $ -75.39MSCPH : SCPHARMACEUTICALS INC $ -85.59MSTXS : STEREOTAXIS INC $ -23.35MLCTX : LINEAGE CELL THERAPEUTICS INC $ -40.91MMGX : METAGENOMI INC $ -90.29MMXCT : MAXCYTE INC $ -44.77M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

FENC - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -24.35M

Minimum

Mar 31, 2023

$ 7.49M

Maximum

Jun 30, 2024

$ -12.92M

Average

$ -17.07M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.62M with a standard deviation of $ 130.62M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 442.4M
average$ 28.62M
median$ 897.02K
std$ 130.62M